All In MedTech

Device Trial Radar · NCT04037735

RSA-RCT: Attune S+ TKA Versus Sigma TKA

A Clinical Randomized Controlled RSA Trial Comparing the Cemented Attune (S+ Tibia Tray) Fixed Bearing Cruciate Retaining Knee System With the Cemented PFC Sigma Fixed Bearing Cruciate Retaining Knee System

Last checked: Nov 19, 2026Latest source record: Oct 30, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

64

Planned (sponsor's estimate)

Start

Nov 1, 2019

Primary completion

Jun 1, 2026

Study completion Jun 1, 2026

Sponsor

Lead sponsor
Peter den HollanderAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Leiden University Medical Center
First posted
Jul 30, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The PFC Sigma Knee by DePuy Synthes is an excellent knee replacement with an excellent clinical track record, good survival rates (98% 10 years survival in patients aged \< 55 years) and minimal early migration as measured with RSA (0.5mm MTPM at two years follow-up). The Attune Knee by DePuy Synthes is an advancement in knee replacement options. It is designed to provide better range of motion and address the unstable feeling some patients experience during everyday activities, such as stair descent and bending. To date, more than 470,000 patients have received an Attune Knee and positive feedback was received regarding patient recovery, stability and motion. The objective of this study is to accurately assess and compare migration, clinical and radiological outcome and patient reported outcomes of two knee prostheses: the Cemented Attune Fixed Bearing Cruciate Retaining Knee System and the Cemented PFC Sigma Fixed Bearing Cruciate Retaining Knee System, both by DePuy Synthes, Warsaw, Indiana, USA. The primary objective of this study is to compare the magnitude and pattern of migration of the prostheses (Femoral and Tibial component). The secondary objective of this study is to compare clinical and radiological outcome of the prostheses and PROMS. This study is designed as a single-blind, randomized trial between the Attune Knee System and PFC Sigma Knee System. 32 patients with the Attune Knee System and 32 patients with PFC Sigma Knee System will be included in this study. The study population will consist of patients with symptomatic osteoarthritis of the knee scheduled for knee replacement surgery at the Department of Orthopaedics, Haags Medisch Centrum The Hague (HMC), The Netherlands. Annually 350 TKA procedures are performed in this department, of which about 90% is Osteo Arthritis (OA) and 10% Rheumatoid Arthritis (RA) and other indications. We anticipate that inclusion can be accomplished within a 1 year period and that the total study duration is 3 years. Main study parameters/endpoints are: * Migration, measured by means of RSA. * Patient Reported Outcome Measures by means of questionnaires.

Conditions

  • Osteoarthritis Arthritis
  • Joint Disease
  • Musculoskeletal Disease
  • Rheumatic Diseases

Interventions

  • ATTUNE S+ Knee Prosthesis by DePuyDevice

    Total Knee Replacement (TKR) Surgery with ATTUNE S+ Knee Prosthesis by DePuy

  • PFC Sigma Knee Prosthesis by DePuyDevice

    Total Knee Replacement Surgery with PFC Sigma Knee Prosthesis by DePuy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Migration, Maximum Total Point Motion (MTPM in mm) measured by means of Radiostereometry (RSA)Time frame: 2 Years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Haaglanden Medical Center

    The Hague, South Holland, Netherlands · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.